Literature DB >> 14179484

THE USE OF FERROKINETICS IN THE EVALUATION OF BUSULPHAN THERAPY IN POLYCYTHAEMIA VERA.

I BRODSKY.   

Abstract

Entities:  

Keywords:  BLOODLETTING; BONE MARROW; BUSULFAN; DRUG THERAPY; ERYTHROPOIESIS; GERIATRICS; HEMATOLOGY; HEMOGLOBIN; HEMOGLOBINOMETRY; IRON METABOLISM; LEUKOCYTOSIS; PHOSPHORUS ISOTOPES; PLASMA; POLYCYTHEMIA VERA; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14179484     DOI： 10.1111/j.1365-2141.1964.tb00705.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug.

Authors:  Emil T Kuriakose; Stefani Gjoni; Y Lynn Wang; Ruth Baumann; Amy V Jones; Nicholas C P Cross; Richard T Silver
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

Review 2.  [Pathogenesis and manifestation of disturbances of erythropoiesis and granulopoiesis in myeloproliferative syndromes].

Authors:  G Meuret; G Hoffmann
Journal:  Klin Wochenschr       Date:  1972-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.